{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:47:15Z","timestamp":1787240835406,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,11,1]]},"DOI":"10.1038\/sj.leu.2401922","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T14:27:43Z","timestamp":1031149663000},"page":"1939-1943","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group"],"prefix":"10.1038","volume":"14","author":[{"given":"A","family":"Biondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MG","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Seriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"D'Aniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MJ","family":"Willemse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pannunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Gadner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WA","family":"Kamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CR","family":"Bartram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JJM","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ER","family":"Panzer-Gr\u00fcmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,11,2]]},"reference":[{"key":"BF2401922_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00062752-199807000-00009","volume":"5","author":"C-H Pui","year":"1998","unstructured":"Pui C-H . Recent advances in the biology and treatment of childhood acute lymphoblastic leukemia Curr Opin Hematol 1998 5: 292\u2013301","journal-title":"Curr Opin Hematol"},{"key":"BF2401922_CR2","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","volume":"84","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H . Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86 Blood 1994 84: 3122\u20133133","journal-title":"Blood"},{"key":"BF2401922_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","volume":"14","author":"M Smith","year":"1996","unstructured":"Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R . Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia J Clin Oncol 1996 14: 18\u201324","journal-title":"J Clin Oncol"},{"key":"BF2401922_CR4","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V81.9.2237.2237","volume":"81","author":"SC Raimondi","year":"1993","unstructured":"Raimondi SC . Current status of cytogenetic research in childhood acute lymphoblastic leukemia Blood 1993 81: 2237\u20132251","journal-title":"Blood"},{"key":"BF2401922_CR5","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B","volume":"80","author":"PS Gaynon","year":"1997","unstructured":"Gaynon PS, Desai AA, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, Reaman GH, Sather HN, Steinherz PG, Trigg ME, Tubergen DG, Uckun FM . Early response to therapy and outcome in childhood acute lymphoblastic leukemia Cancer 1997 80: 1717\u20131726","journal-title":"Cancer"},{"key":"BF2401922_CR6","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1200\/JCO.1996.14.8.2403","volume":"14","author":"M Schrappe","year":"1996","unstructured":"Schrappe M, Reiter A, Riehm H . Cytoreduction and prognosis in childhood acute lymphoblastic leukemia J Clin Oncol 1996 14: 2403\u20132406","journal-title":"J Clin Oncol"},{"key":"BF2401922_CR7","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(96)91615-3","volume":"347","author":"Group Childhood ALL Collaborative","year":"1996","unstructured":"Childhood ALL Collaborative Group . Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukemia: overview of 42 trials involving 12 000 randomised children Lancet 1996 347: 1783\u20131788","journal-title":"Lancet"},{"key":"BF2401922_CR8","first-page":"3310","volume":"95","author":"M Schrappe","year":"2000","unstructured":"Schrappe M, Reiter A, Ludwig W-D, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, Kornhuber B, Ritter J, Welte K, Gadner H, Riehm H . Improved outcome in childhood ALL despite reduced use of anthracyclines and of cranial radiotherapy. Results of trial ALL-BFM 90 Blood 2000 95: 3310\u20133322","journal-title":"Blood"},{"key":"BF2401922_CR9","first-page":"791","volume":"83","author":"V Conter","year":"1998","unstructured":"Conter V, Aric\u00f2 M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G . Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study Haematologica 1998 83: 791\u2013799","journal-title":"Haematologica"},{"key":"BF2401922_CR10","first-page":"169a","volume":"33","author":"WA Kamps","year":"1999","unstructured":"Kamps WA, B\u00f6kkerink JP, Hakvoort-Cammel FG, Weening RS, Verman AJ, Weeden JF, van Wering ER, van der Does-van der Berg A . Results of the DCLSG-study ALL8 (1991\u20131997): BFM-oriented treatment without cranial irradiation (CI) and comparing conventional oral and high doses intravenous 6-mercaptopurine Med Ped Oncol 1999 33: 169a","journal-title":"Med Ped Oncol"},{"key":"BF2401922_CR11","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1200\/JCO.1992.10.12.1879","volume":"10","author":"R Wasserman","year":"1992","unstructured":"Wasserman R, Galili N, Ito Y, Silber JH, Reichard BA, Shane S, Womer RB, Lange B, Rovera G . Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia J Clin Oncol 1992 10: 1879\u20131888","journal-title":"J Clin Oncol"},{"key":"BF2401922_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0140-6736(94)90988-1","volume":"343","author":"MJ Brisco","year":"1994","unstructured":"Brisco MJ, Condon J, Hughes E, Neoh SH, Sykes PJ, Seshadri R, Toogood I, Waters K, Tauro G, Ekert H, Morley A . Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction Lancet 1994 343: 196\u2013200","journal-title":"Lancet"},{"key":"BF2401922_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJM199808273390904","volume":"339","author":"H Cave","year":"1998","unstructured":"Cave H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E . Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia New Engl J Med 1998 339: 591\u2013598","journal-title":"New Engl J Med"},{"key":"BF2401922_CR14","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJ van Dongen","year":"1998","unstructured":"van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, de Bruijn MA, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WC, Riehm H, Bartram CR . Prognostic value of minimal residual disease in acute lymphoblastic leukemia in childhood Lancet 1998 352: 1731\u20131738","journal-title":"Lancet"},{"key":"BF2401922_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","volume":"351","author":"E Coustan-Smith","year":"1998","unstructured":"Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC, Rubnitz JE, Rivera GK, Sandlund JT, Pui CH, Campana D . Immunological detection of minimal residual disease in children with acute lymphoblastic leukemia Lancet 1998 351: 550\u2013554","journal-title":"Lancet"},{"key":"BF2401922_CR16","volume-title":"Analysing Survival Data from Clinical Trials and Observational Studies. John Wiley","author":"E Marubini","year":"1995","unstructured":"Marubini E, Valsecchi MG . Analysing Survival Data from Clinical Trials and Observational Studies. John Wiley Chichester 1995"},{"key":"BF2401922_CR17","volume-title":"Statistical Methods in Cancer Research, vol. 1: The Analysis of Case-Control Studies","author":"NE Breslow","year":"1980","unstructured":"Breslow NE, Day NE . Statistical Methods in Cancer Research, vol. 1: The Analysis of Case-Control Studies International Agency for Research in Cancer: London 1980"},{"key":"BF2401922_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression models and life-tables (with discussion) J Roy Stat Soc 1972 34: 187\u2013220","journal-title":"J Roy Stat Soc"},{"key":"BF2401922_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.leu.2401245","volume":"13","author":"MJ Pongers-Willemse","year":"1999","unstructured":"Pongers-Willemse MJ, Seriu T, Stolz F, d'Aniello E, Gameiro P, Pisa P, Gonzalez M, Bartram CR, Panzer-Grumayer ER, Biondi A, San Miguel JF, van Dongen JJ . Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia Leukemia 1999 13: 110\u2013118","journal-title":"Leukemia"},{"key":"BF2401922_CR20","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/sj.leu.2400904","volume":"11","author":"A Beishuizen","year":"1997","unstructured":"Beishuizen A, de Bruijn MA, Pongers-Willemse MJ, Verhoeven MA, van Wering ER, Hahlen K, Breit TM, de Bruin-Versteeg S, Hooijkass H, van Dongen JJ . Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease Leukemia 1997 11: 2200\u20132207","journal-title":"Leukemia"},{"key":"BF2401922_CR21","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1200\/JCO.1997.15.3.1150","volume":"15","author":"JE Rubnitz","year":"1997","unstructured":"Rubnitz JE, Downing JR, Pui CH, Shurtleff SA, Raimondi SC, Evans WE, Head DR, Crist WM, Rivera GK, Hancock ML, Boyett JM, Buijs A, Grosveld G, Behm FG . TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance J Clin Oncol 1997 15: 1150\u20131157","journal-title":"J Clin Oncol"},{"key":"BF2401922_CR22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V90.2.571","volume":"90","author":"A Borkhardt","year":"1997","unstructured":"Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L, Mangioni S, Schrappe M, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A . Incidence and clinical relevance of TEL\/AML 1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italia multicenter therapy trials Blood 1997 90: 571\u2013577","journal-title":"Blood"},{"key":"BF2401922_CR23","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1182\/blood.V87.8.3368.bloodjournal8783368","volume":"87","author":"S Takeuchi","year":"1996","unstructured":"Takeuchi S, Bartram CR, Miller CW, Reiter A, Seriu T, Zimmerann M, Schrappe M, Mori N, Slater J, Miyoshi I, Koeffler HP . Acute lymphoblastic leukemia of childhood. Identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1 Blood 1996 87: 3368\u20133374","journal-title":"Blood"},{"key":"BF2401922_CR24","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/sj.leu.2400779","volume":"11","author":"JE Rubnitz","year":"1997","unstructured":"Rubnitz JE, Behm FG, Pui CH, Evans WE, Relling MV, Raimondi SC, Harrison PL, Sandlund JT, Ribeiro RC, Grosveld G, Downing JR . Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV gene abnormalities: results of St Jude Total Therapy Study XII Leukemia 1997 11: 1210\u20131206","journal-title":"Leukemia"},{"key":"BF2401922_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1365-2141.1996.d01-1753.x","volume":"94","author":"A Sauerbrey","year":"1996","unstructured":"Sauerbrey A, Stammler G, Zintl F, Volm M . Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukemia Br J Haematol 1996 94: 99\u2013104","journal-title":"Br J Haematol"},{"key":"BF2401922_CR26","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","volume":"338","author":"JB Nachman","year":"1998","unstructured":"Nachman JB, Sather HN, Sensel MG, Trigg ME, Cherlow JM, Lukens JN, Wolff L, Uckun FM, Gaynon PS . Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a low response to initial therapy New Engl J Med 1998 338: 1663\u20131671","journal-title":"New Engl J Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401922","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T06:06:27Z","timestamp":1733551587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,1]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11,1]]}},"alternative-id":["BF2401922"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401922","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11,1]]},"assertion":[{"value":"30 December 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}